Mechanisms of altered excitation-contraction coupling in canine tachycardia-induced heart failure, I: experimental studies.

Pacing-induced heart failure in the dog recapitulates many of the electrophysiological and hemodynamic abnormalities of the human disease; however, the mechanisms underlying altered Ca2+ handling have not been investigated in this model. We now show that left ventricular midmyocardial myocytes isolated from dogs subjected to 3 to 4 weeks of rapid pacing have prolonged action potentials and Ca2+ transients with reduced peaks, but durations approximately 3-fold longer than controls. To discriminate between action potential effects on Ca2+ kinetics and direct changes in Ca2+ regulatory processes, voltage-clamp steps were used to examine the time constant for cytosolic Ca2+ removal (tauCa). tauCa was prolonged by just 35% in myocytes from failing hearts after fixed voltage steps in physiological solutions (tauCa control, 216+/-25 ms, n=17; tauCa failing, 292+/-23 ms, n=22; P<0.05), but this difference was markedly accentuated when Na+/Ca2+ exchange was eliminated (tauCa control, 282+/-30 ms, n=13; tauCa failing, 576+/-83 ms, n=11; P<0. 005). Impaired sarcoplasmic reticular (SR) Ca2+ uptake and a greater dependence on Na+/Ca2+ exchange for cytosolic Ca2+ removal was confirmed by inhibiting SR Ca2+ ATPase with cyclopiazonic acid, which slowed Ca2+ removal more in control than in failing myocytes. beta-Adrenergic stimulation of SR Ca2+ uptake in cells from failing hearts sufficed only to accelerate tauCa to the range of unstimulated controls. Protein levels of SERCA2a, phospholamban, and Na+/Ca2+ exchanger revealed a pattern of changes qualitatively similar to the functional measurements; SERCA2a and phospholamban were both reduced in failing hearts by 28%, and Na+/Ca2+ exchange protein was increased 104% relative to controls. Thus, SR Ca2+ uptake is markedly downregulated in failing hearts, but this defect is partially compensated by enhanced Na+/Ca2+ exchange. The alterations are similar to those reported in human heart failure, which reinforces the utility of the pacing-induced dog model as a surrogate for the human disease.

[1]  Donald M. Bers,et al.  Excitation-Contraction Coupling and Cardiac Contractile Force , 1991, Developments in Cardiovascular Medicine.

[2]  R. Winslow,et al.  Mechanisms of altered excitation-contraction coupling in canine tachycardia-induced heart failure, II: model studies. , 1999, Circulation research.

[3]  G Arnold,et al.  Evidence for functional relevance of an enhanced expression of the Na(+)-Ca2+ exchanger in failing human myocardium. , 1996, Circulation.

[4]  Role of the Cardiac Sarcolemmal Na+‐Ca2+ Exchanger in End‐Stage Human Heart Failure , 1996, Annals of the New York Academy of Sciences.

[5]  D. Kass,et al.  Ionic mechanism of action potential prolongation in ventricular myocytes from dogs with pacing-induced heart failure. , 1996, Circulation research.

[6]  S. Lemaire,et al.  High frequency-induced upregulation of human cardiac calcium currents. , 1996, Circulation.

[7]  M. Böhm,et al.  Unchanged protein levels of SERCA II and phospholamban but reduced Ca2+ uptake and Ca(2+)-ATPase activity of cardiac sarcoplasmic reticulum from dilated cardiomyopathy patients compared with patients with nonfailing hearts. , 1995, Circulation.

[8]  C H Davies,et al.  Reduced contraction and altered frequency response of isolated ventricular myocytes from patients with heart failure. , 1995, Circulation.

[9]  S. Hamilton,et al.  Effect of ryanodine on sarcoplasmic reticulum Ca2+ accumulation in nonfailing and failing human myocardium. , 1995, Circulation.

[10]  F. del Monte,et al.  Cell geometry and contractile abnormalities of myocytes from failing human left ventricle. , 1995, Cardiovascular research.

[11]  E. Erdmann,et al.  Altered diastolic [Ca2+]i handling in human ventricular myocytes from patients with terminal heart failure. , 1995, American heart journal.

[12]  R A Bassani,et al.  Calibration of indo-1 and resting intracellular [Ca]i in intact rabbit cardiac myocytes. , 1995, Biophysical journal.

[13]  J M de Bakker,et al.  Triggered activity and automaticity in ventricular trabeculae of failing human and rabbit hearts. , 1994, Cardiovascular research.

[14]  H. Drexler,et al.  Gene expression of the cardiac Na(+)-Ca2+ exchanger in end-stage human heart failure. , 1994, Circulation research.

[15]  M. Movsesian,et al.  Ca(2+)-transporting ATPase, phospholamban, and calsequestrin levels in nonfailing and failing human myocardium. , 1994, Circulation.

[16]  G. Hasenfuss,et al.  Influence of the force-frequency relationship on haemodynamics and left ventricular function in patients with non-failing hearts and in patients with dilated cardiomyopathy. , 1994, European heart journal.

[17]  G. Klein,et al.  Arrhythmogenic effects of catecholamines are decreased in heart failure induced by rapid pacing in dogs. , 1993, The American journal of physiology.

[18]  E Erdmann,et al.  Characteristics of transient outward current in human ventricular myocytes from patients with terminal heart failure. , 1993, Circulation research.

[19]  E. Erdmann,et al.  Alterations of K+ currents in isolated human ventricular myocytes from patients with terminal heart failure. , 1993, Circulation research.

[20]  N. Alpert,et al.  Alterations in sarcoplasmic reticulum gene expression in human heart failure. A possible mechanism for alterations in systolic and diastolic properties of the failing myocardium. , 1993, Circulation research.

[21]  Dana,et al.  Abnormalities in intracellular calcium regulation and contractile function in myocardium from dogs with pacing-induced heart failure. , 1992, The Journal of clinical investigation.

[22]  E Erdmann,et al.  Intracellular Calcium Handling in Isolated Ventricular Myocytes From Patients With Terminal Heart Failure , 1992, Circulation.

[23]  G. Klein,et al.  Electrophysiologic substrate associated with pacing-induced heart failure in dogs: potential value of programmed stimulation in predicting sudden death. , 1992, Journal of the American College of Cardiology.

[24]  A. Mazzucco,et al.  Contractile Properties and Ca2+ Release Activit of the Sarcoplasmic Reticulum in Dilated Cardiomyopathy , 1992, Circulation.

[25]  E Erdmann,et al.  Ca(2+)-currents and intracellular [Ca2+]i-transients in single ventricular myocytes isolated from terminally failing human myocardium. , 1992, Basic research in cardiology.

[26]  R. Schwinger,et al.  Alterations of the force-frequency relationship in the failing human heart depend on the underlying cardiac disease. , 1992, Basic research in cardiology.

[27]  E. Neher.  Correction for liquid junction potentials in patch clamp experiments. , 1992, Methods in enzymology.

[28]  H A Fozzard,et al.  Afterdepolarizations and triggered activity. , 1992, Basic research in cardiology.

[29]  J. Morgan,et al.  Pathophysiology of cardiac hypertrophy and failure of human working myocardium: abnormalities in calcium handling. , 1992, Basic research in cardiology.

[30]  F. Schoen,et al.  Post-extrasystolic potentiation and the force-frequency relationship: differential augmentation of myocardial contractility in working myocardium from patients with end-stage heart failure. , 1990, Journal of molecular and cellular cardiology.

[31]  M. Böhm,et al.  Positive inotropic effects in isolated ventricular myocardium from non‐failing and terminally failing human hearts , 1988, European journal of clinical investigation.

[32]  M. Böhm,et al.  Reduction of beta-adrenoceptor density and evaluation of positive inotropic responses in isolated, diseased human myocardium. , 1988, European heart journal.

[33]  J. Morgan.  Intracellular calcium in heart failure , 1988, Cardiovascular drugs and therapy.

[34]  W Grossman,et al.  Abnormal intracellular calcium handling in myocardium from patients with end-stage heart failure. , 1987, Circulation research.

[35]  F. Schoen,et al.  Deficient production of cyclic AMP: pharmacologic evidence of an important cause of contractile dysfunction in patients with end-stage heart failure. , 1987, Circulation.

[36]  M. Bristow,et al.  Assessment of the beta-adrenergic receptor pathway in the intact failing human heart: progressive receptor down-regulation and subsensitivity to agonist response. , 1986, Circulation.

[37]  R. Tsien,et al.  A new generation of Ca2+ indicators with greatly improved fluorescence properties. , 1985, The Journal of biological chemistry.

[38]  W. Newman.  Volume overload heart failure: length-tension curves, and response to beta-agonists, Ca2+, and glucagon. , 1978, The American journal of physiology.